Member Info for BOJO2020

Johnny,

I think it best to email Scancell and pose the question as things may have changed since RNS?

I have emailed them at 9am regarding something else but still waiting for a response.

GF,

With respect. RR has been asking pertinent questions, which by the way people should feel free to answer. These answers will be scrutinsed by members here and debated. People will make their own minds up! I think there are clearly people frequenting this board that are here to cause disruption, manipulate the share price and misrepresent anything they can, yourself and Ruck Rover are NOT among them.

I am with Ruck,

We need to delineate what is stable. We will hopefully see mention of this (or better) many times to come with Modi and SCIB updates. If nobody emails investor relations I will.

I have another question: Is tumor status different in each cancer type or specific to each patient. If it were cancer type it may explain why we see so many with stable disease?

Yes. I hope what I said earlier didn’t come across as all opinionated or narky. It’s just that we now have 23 x different experiences so far.

Is it fair to say the conversation is about twenty three patients now, not just one?

Just saying: maybe TM deserves a break with all she has and is dealing with. Lots to occupy our minds otherwise. I mean it is likely that there will be a range of clinical reactions that are completely different. Even though this could be a pan cancer vaccine one day.

Thanks Burble

Lots of positives to look at

Thanks Burble,

So delayed regression is possible or at least was in the case you highlighted.

Q. As it appears delayed regression could be a possibility with Modi - 1 also, if you were part of the Scancell team, would you have factored this in as an expected possibility before stating the trial. In other words is it known to happen commonly?

ATB

Good luck Dibs61!

Nice to see you here. We have had a rotten run on the other share but very optimistic for that and Scancell over time.

ATB

As I understand it, CI's are not appropriate for all patients. For this reason I am especially keen to see the ovarian side of the study. It is not only what Moditope can do in combination with CI, but on its own. CI can cause adverse effects and be of little use in some cases.

Please correct me if I am wrong.

Thanks ciaskin. Two good posts

Scancell relaying fact rather than driving expectancy. Very professional as one would expect. Agree, the RNS sets a good tone.

Violin Dog,

The share price rises and falls. Becoming concerned is not advisable as there really is nothing we can do about it. It is a bit like being on a roller coaster; the ups and downs cant harm you so why not sit back and relax? I can assure you, everything that is going to happen with the stock WILL happen, regardless of whether i scream and shout, panic, get angry, whinge or whine...

My voice (along with everyone else's on these bulletin board's) is all but a blue bottle hitting the windscreen at 70mph on the epic Scancell journey!

ATB

Hi LL,

I do not have any concerns about the share price movements of late. In time it will reflect our true value and we might have to wait for that. Fine by me!

ATB

Is it me, or did it just take three days to find out that these two agreed (in the first place?)

**theme of the update

Anything other than commercialisation: contracts etc would be a distraction imo. The time of the update suggests that Angle are attempting to focus?

Regarding those mice... (sorry to the subject up again)

"The effect is caused by key unique sequence residues that are present in the mouse but not seen in the equivalent human antibodies. Essentially AvidiMab can transfer these active residues to any target humanised antibody and so enhance non-covalent interactions between any mAb (or similarly structured) molecules resulting in a material improvement in avidity and potency."

This is an exert from the TD note. Have we all read the entire document? If not why not!

Is the next thread title going to:

Follow that rainbow?

The next being:

And your dreams will all come true?

Watch out or S Club7 may sue

Jokers…

Two lovely innings played by one of Scancells star batsman: Immunobody!

SCIB1 phase 1 what a blinder!
Covidity phase 1 a very solid performance despite an inhospitable environment!

Great promise also shown by the up and coming AvidiMab!

Also a notable performance from on loan pharma jet

Just like a test match. Worth the wait IMO

https://youtu.be/WdTQcGf4Ios

Who knew! (not me haha!)